Placental graft for diabetic foot ulcers that didn't close
Part of Heart & circulation, Hormones & metabolism, Skin clinical trials.
This trial tests a placental-based graft for diabetic foot ulcers that did not heal after 12 weeks of standard care in a previous study (CAMPX). It aims to help people whose wounds are still open despite good wound care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have type 1 or 2 diabetes.
- You took part in the CAMPX study and received only standard care (not the experimental treatment) for a foot ulcer that did not fully heal in 12 weeks.
- The ulcer we will treat must be the same one from the CAMPX study.
- You agree to use a special offloading device (like a boot or cast) to take pressure off the ulcer during the study.
- You can attend weekly clinic visits for the study duration.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special placental tissue graft placed on a diabetic foot ulcer helps it heal faster than standard wound care alone. It is for people with a diabetic foot ulcer that has not healed after 4 weeks of usual care.
This study tests whether a special wound dressing made from human placental membrane can help heal diabetic foot ulcers or venous leg ulcers that did not close with standard care. It is for people who were in the BIOCAMP trial and whose ulcer remained open after 12 weeks of standard treatment.
This trial tests a treatment made from placental tissue, called Bioxheal, which is placed on a diabetic foot ulcer to help it heal. It compares this treatment to standard care alone.
This trial compares several advanced wound treatments (called CAMPs) plus standard care versus standard care alone for diabetic foot ulcers that are slow to heal. The goal is to see if adding these treatments helps ulcers close faster.
This trial tests whether a special treatment using placental cells can help heal diabetic foot ulcers that haven't healed with standard care. If you qualify, you may receive this cell-based treatment to see if it helps your wound close faster and reduce the risk of complications.
This trial tests if adding a special placenta-based wound covering to standard care helps heal diabetic foot ulcers and venous leg ulcers faster. It's for people with wounds that haven't healed after standard treatment for at least 4 weeks.
Hear when a new Diabetic Foot trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.